GlassScriptPhysician profile
Avnit K Ahuja
NPI 1962616474
$11,646.94
in general payments reported to CMS, 2019-2025
37 companies · $3,181 in 2025
The $3,181 reported for 2025 was more than what 78% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $606 · 2021: $509 · 2022: $1,279 · 2023: $2,737 · 2024: $2,554 · 2025: $3,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,084 · Education: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,083.71 |
| Education | $388.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,006.37 | 2019-2025 | Enbrel, Otezla, Tavneos |
| Abbvie INC. | $1,220.00 | 2019-2025 | Rinvoq, Skyrizi, Humira |
| Ucb, INC. | $1,131.78 | 2019-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $1,102.63 | 2019-2025 | |
| Janssen Biotech, INC. | $983.54 | 2019-2025 | Tremfya, Simponi Aria, Remicade |
| Pfizer INC. | $869.16 | 2019-2025 | |
| Glaxosmithkline, LLC. | $417.80 | 2019-2025 | Benlysta |
| Astrazeneca Pharmaceuticals LP | $408.87 | 2021-2025 | Saphnelo, Evusheld |
| Horizon Therapeutics Plc | $403.63 | 2021-2023 | Krystexxa |
| Radius Health, INC. | $400.23 | 2019-2025 | Tymlos |
| Lilly USA, LLC | $369.39 | 2019-2024 | Taltz |
| Ani Pharmaceuticals, INC. | $363.27 | 2022-2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $292.37 | 2021-2025 | Acthar |
| Genentech USA, INC. | $182.27 | 2019-2025 | Actemra, Gazyva |
| E.R. Squibb & Sons, L.L.C. | $163.71 | 2019-2025 | Orencia |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avnit Ahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.